Knowledge Distillery

The serotonin reuptake inhibitor Fluoxetine inhibits SARS-CoV-2 in human lung tissue

Clofazimine broadly inhibits coronaviruses including SARS-CoV-2

A conserved immunogenic and vulnerable site on the coronavirus spike protein delineated by cross-reactive monoclonal antibodies

Estimated transmissibility and impact of SARS-CoV-2 lineage B.1.1.7 in England

Structural impact on SARS-CoV-2 spike protein by D614G substitution

Susceptibility of neuroblastoma and glioblastoma cell lines to SARS-CoV-2 infection

Human neutralizing antibodies against SARS-CoV-2 require intact Fc effector functions for optimal therapeutic protection

Reduced neutralization of SARS-CoV-2 B.1.1.7 variant by convalescent and vaccine sera

The antigenic anatomy of SARS-CoV-2 receptor binding domain

Neutralization of SARS-CoV-2 lineage B.1.1.7 pseudovirus by BNT162b2 vaccine–elicited human sera

Recurrent deletions in the SARS-CoV-2 spike glycoprotein drive antibody escape

Assessing the influence of climate on wintertime SARS-CoV-2 outbreaks